Michalis is a driven entrepreneur with a vision to deliver innovative healthcare technologies that transform patient treatment. As the founder and CEO of Brainomix, an award-winning, University of Oxford AI medical imaging spin-out, he has grown the company from the ground up, building its global presence. Michalis has raised more than £13 million of investment and public funding to grow Brainomix and has significant experience in innovative start-ups, as he have led the development, regulatory clearance and commercialisation of AI-based medical imaging software. He has also forged strong partnerships with pharmaceutical and medical device companies. Previously, he was the Scientific Director of the preclinical stroke lab at the University of Oxford and he has a PhD in neurosciences from UCL School of Pharmacy. Michalis has been an invited speaker at international stroke conferences and innovation events, and he has mentored emerging teams at international innovation competitions.